Tweets
❤️ Beta Blockers in LV-GCA
📚65 pts LV-GCA
💊 15(23%) on BB, 50(73%) not
🩻 new aortic dilatation on serial imaging in 15 (23%) - ALL in those NOT on beta blocker 💔
More studies needed, but supportive initial data 🔥
@RheumNow #ACR22 Abst#0477
Patricia Harkins @DrTrishHarkins ( View Tweet )
3 years 8 months ago
#abs0127 #acr22 @rheumnow 59 adults pts from SAPHO-CNO Study (SCS) reported high scores (0.8 or >SD) for pain interference& fatigue domains vs general population. ⬇️ score on PROMIS physical function; 72.9% of subjects had a T-score < 45. https://t.co/5QfwlB98wV
Olga Petryna @DrPetryna ( View Tweet )
3 years 8 months ago
#ACR22 Abstr#0769 In patients on DMARDs who didnt seroconvert after primary mRNA COVID vac, is switching to vector or booster with mRNA more effective? An RCT (N=46) showed more pts receiving booster mRNA seroconverted (63%) vs vector (18%). Tcell response was similar @RheumNow https://t.co/5GTsdhNUQZ
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
3 years 8 months ago
Barajas-Ochoa et al. Gender representation in editorial boards of rheum journals. Only 28% women editors overall. Clear discrepancies between journals. Well done @ACR_Journals ! @rheumnow #ACR22 Abstr#104 https://t.co/dpElAUSEuS https://t.co/rDAG6HwNf4
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
Neural networks help distinguish between inflammatory arthritis, RA vs PsA, based on MRI inflammatory patterns, focusing on regions of clinical relevance. Fascinating use of tech that needs to be further evaluated clinically. Abs 0242 #ACR22 @RheumNow https://t.co/EMJZkFaMwu https://t.co/hNf70PaZX6
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
❓Vessel wall MRI superior to TA-US in c-GCA❓
🔥In c-GCA vessel wall MRI examines beyond the temporal arteries -
✅more 🧠 cranial arteries, including occipital arteries and the all important 👁 orbital structures
Abst#0473
#ACR22 @RheumNow @RennieRhee https://t.co/ayuPP5v7Lh
Patricia Harkins @DrTrishHarkins ( View Tweet )
3 years 8 months ago
Tune in to Twitter, Facebook or LinkedIn daily at 5pm ET! #ACR22 https://t.co/BPlVx0rRCd
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
Prieto-Pena et al. Tocilizumab in GCA and TAK. Observational study of 70 GCA, 57 TAK in Spain. Similar efficacy in both diseases. @rheumnow #ACR22 Abstr#0465 https://t.co/pyKAILryhH https://t.co/Csp7FIgnzD
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
After bDMARD treatment for 1 year in AxSpA, the gut microbiota composition:
◦ more resembled controls
◦ Enrichment of Collinsella remained stable
◦ Depletion of some species in HLA-B27+ patients from baseline
https://t.co/Mw4MToqFcQ
Poddubnyy et al @ProftDr #ACR22 @RheumNow
Dr. Antoni Chan @synovialjoints ( View Tweet )
3 years 8 months ago
#ACR22 Abs 0256 identified different autoantibodies in ACPA+ and ACPA– RA. Study shows potential utility of serum autoantibodies as diagnostic targets for RA subgroups & treatments. This study reminds me of @RheumNow teaching that not all RA created equal. https://t.co/Fjjk6uC0pB https://t.co/Ozr32cJojr
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
“It's not that I'm so smart, it's just that I stay with problems longer.” Einstein
Love the quote in the community hub for early career @NIAMSFunding - Perseverance is the KEY in this funding world #ACR22 @RheumNow
Bella Mehta @bella_mehta ( View Tweet )
3 years 8 months ago
Figueroa-Parra et al @AliDuarteMD Preventative services in SLE better in some areas and worse in some than comparators. Overall cervical screening, osteoporosis, dyslipidaemia low in this high risk group @rheumnow #ACR22 Abstr#0064 https://t.co/fHQ7ct6yt5 https://t.co/x7gHUDA8zo
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
